GSK3B and neoplasm: Sahin et al. underscored the appeal of selective GSK-3β inhibitors as therapeutic targets, owing to their pivotal roles in regulating apoptosis, the cell cycle, DNA repair, tumor growth, invasion, and metastasis, as well as their capacity to modulate anticancer immune responses.21